Drug dosing in obese patients continues to be challenging due to a lack of high‐quality
evidence to guide dosing recommendations. We first published guidance for antibiotic …

The prevalence of obesity has increased considerably in the last few decades.
Pathophysiological changes in obese patients lead to pharmacokinetic (PK) and …

Background: Increasing evidence suggests that administration of combination vancomycin
and piperacillin-tazobactam (VPT) increases the incidence of acute kidney injury (AKI) …